Charles Russell Speechlys advises Kreos Capital and Silicon Valley Bank on £20 million growth capital investment in Mereo BioPharma
Charles Russell Speechlys have advised Kreos Capital and Silicon Valley Bank on a £20 million growth capital investment in Mereo BioPharma, a UK-based specialty bio-pharmaceutical company listed on the AIM market of the London Stock Exchange.
Mereo BioPharma was established to address the R&D and financial challenges faced by an increasing number of large pharmaceutical and biotech companies, and to optimise drug development and ensure that promising drug candidates fulfil their potential.
Mereo BioPharma announced to the market that it will use the financing to increase its operational and development flexibility.
The Charles Russell Speechlys core team comprised Chris Putt (Partner), Rossana Conti (Senior Associate), Amelly Kok (Associate) and Olivia Mackie (Associate) from our Corporate Team, and Daniel Sullivan (Partner) and Susan Mitchell (Senior Associate) from our Banking Team.”
News & Insights
Charles Russell Speechlys named as one of the 1000 Companies to inspire Britain 2018
1000 Companies to Inspire Britain is an annual celebration of some of the fastest-growing and most dynamic SMEs in the UK.
Takeover Code amendments: what you need to know and how the new rules will change the takeover process in practice
We highlight what you need to know and explain how the new rules will change the takeover process in practice.
Charles Russell Speechlys advises on the management buy-out of Principle Cleaning Services
PCS is a market leader in providing corporate, commercial cleaning in London to some of the most famous landmark buildings in the Capital.
Charles Russell Speechlys advises Civica on the acquisition of Nationwide Retail Systems Limited
NRS is an established provider of integrated payment solutions, most notably for the education sector.